应激性心肌病的诊断与治疗:JACC 最新综述
应激性心肌病是一种急性可逆性心力衰竭综合征,虽临床病程自限,但可发生室性心律失常、系统性血栓栓塞和心源性休克等严重并发症。随着认识提高,其发病率呈上升趋势(每年每10万人15-30例),但真实发病率仍未知,可能被低估。本文综述了该综合征的风险因素、触发因素及诊断治疗实用方法,并指出潜在挑战与未解问题。
要点
- 应激性心肌病并非良性,可并发室性心律失常、血栓栓塞和心源性休克。
- 发病率报告为每年每10万人15-30例,但真实发病率可能被低估。
- 该病属神经心源性心肌顿抑,脑-心联系明确但确切机制未明。
核心结论
- 应激性心肌病是急性可逆性心衰综合征,伴不可忽视的严重并发症风险。
- 发病率呈上升趋势,但真实发病率未知,可能诊断不足。
研究设计与样本
- 本文为JACC最新综述,回顾了应激性心肌病的风险因素、触发因素及诊断治疗方法。
主要发现
- 应激性心肌病可发生室性心律失常、系统性血栓栓塞和心源性休克等严重并发症。
- 报告发病率为每年每10万人15-30例,但真实发病率未知。
- 该病代表一种神经心源性心肌顿抑,脑-心联系已确立但病理生理机制未明。
临床怎么用
- 临床应认识到应激性心肌病并非良性,需警惕严重并发症。
- 对疑似患者应综合评估风险因素和触发因素,并遵循实用诊断与治疗路径。
局限性
- 确切病理生理机制仍未明确。
- 真实发病率未知,可能因诊断不足而被低估。
- 存在未解决的问题和诊断治疗挑战。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
Stress cardiomyopathy is an acute reversible heart failure syndrome initially believed to represent a benign condition due to its self-limiting clinical course, but now recognized to be associated with a non-negligible rate of serious complications such as ventricular arrhythmias, systemic thromboembolism, and cardiogenic shock. Due to an increased awareness and recognition, the incidence of stress cardiomyopathy has been rising (15-30 cases per 100,000 per year), although the true incidence is unknown as the condition is likely underdiagnosed. Stress cardiomyopathy represents a form of neurocardiogenic myocardial stunning, and while the link between the brain and the heart is established, the exact pathophysiological mechanisms remain unclear. We herein review the proposed risk factors and triggers for the syndrome and discuss a practical approach to diagnosis and treatment of the patients with stress cardiomyopathy, highlighting potential challenges and unresolved questions.
引用
- Medina de Chazal H, Del Buono MG, Keyser-Marcus L, et al. Stress Cardiomyopathy Diagnosis and Treatment: JACC State-of-the-Art Review. J Am Coll Cardiol. 2018. PMID: 30309474. doi:10.1016/j.jacc.2018.07.072
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。